Montreal, December 17th 2015 – In a study published in the prestigious scientific journal Cell Reports, the research team of Dr. Gaétan Mayer, director of the molecular cell biology laboratory at the Montreal Heart Institute and professor of medicine at Université de Montréal, identified a liver protein that protects the receptor responsible of eliminating circulating LDL-cholesterol, the “bad cholesterol”, from degradation by the protein PCSK9.